CRIS Current Research Information System

CICERO, ARRIGO FRANCESCO GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.916
NA - Nord America 25.529
AS - Asia 9.258
AF - Africa 904
SA - Sud America 183
OC - Oceania 121
Continente sconosciuto - Info sul continente non disponibili 13
Totale 61.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.437
IT - Italia 11.366
GB - Regno Unito 5.477
CN - Cina 3.234
DE - Germania 2.831
SG - Singapore 2.320
VN - Vietnam 1.671
IN - India 1.274
SE - Svezia 1.261
UA - Ucraina 1.126
FR - Francia 863
IE - Irlanda 731
RU - Federazione Russa 696
ZA - Sudafrica 463
EE - Estonia 378
NL - Olanda 212
CH - Svizzera 203
TG - Togo 160
CI - Costa d'Avorio 143
JO - Giordania 125
ID - Indonesia 114
BG - Bulgaria 113
AU - Australia 105
GR - Grecia 104
FI - Finlandia 99
BE - Belgio 94
BR - Brasile 92
HK - Hong Kong 92
SC - Seychelles 86
PL - Polonia 83
CA - Canada 66
JP - Giappone 56
ES - Italia 55
TR - Turchia 54
KR - Corea 50
IR - Iran 47
CL - Cile 42
AT - Austria 40
PE - Perù 39
RO - Romania 38
PK - Pakistan 37
LB - Libano 30
TW - Taiwan 25
NG - Nigeria 24
MY - Malesia 20
HR - Croazia 17
MX - Messico 17
NZ - Nuova Zelanda 16
AE - Emirati Arabi Uniti 15
RS - Serbia 15
AL - Albania 14
CZ - Repubblica Ceca 14
PH - Filippine 14
NO - Norvegia 12
EG - Egitto 11
LK - Sri Lanka 11
KZ - Kazakistan 10
LU - Lussemburgo 10
PT - Portogallo 10
TH - Thailandia 10
SA - Arabia Saudita 9
EU - Europa 8
MC - Monaco 8
BD - Bangladesh 7
HU - Ungheria 7
IQ - Iraq 7
SK - Slovacchia (Repubblica Slovacca) 7
SI - Slovenia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
EC - Ecuador 5
IL - Israele 5
MT - Malta 5
TN - Tunisia 5
UZ - Uzbekistan 5
AR - Argentina 4
DZ - Algeria 4
LT - Lituania 4
CU - Cuba 3
DO - Repubblica Dominicana 3
LV - Lettonia 3
SM - San Marino 3
AM - Armenia 2
BY - Bielorussia 2
CM - Camerun 2
CY - Cipro 2
GT - Guatemala 2
KE - Kenya 2
KH - Cambogia 2
MA - Marocco 2
MN - Mongolia 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CO - Colombia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
Totale 61.918
Salva come PNG Salva come JPEG
Città #
Southend 4.932
Fairfield 3.494
Singapore 2.002
Ashburn 1.781
Woodbridge 1.727
Chandler 1.719
Wilmington 1.561
Seattle 1.489
Princeton 1.405
Houston 1.381
Cambridge 1.195
Dong Ket 1.055
Santa Clara 988
Milan 939
Ann Arbor 849
Boardman 826
Dublin 713
Jacksonville 678
Rome 666
Bologna 583
Westminster 537
Padova 509
Nanjing 497
Berlin 383
Turin 321
Saint Petersburg 257
Bremen 242
San Diego 239
Naples 227
Jinan 215
Shenyang 199
Florence 170
Beijing 165
Nanchang 161
Lomé 160
Mülheim 147
Abidjan 143
Hebei 139
Amman 124
Des Moines 120
Changsha 118
Medford 118
Tianjin 114
Sofia 109
Bari 104
Dearborn 102
Shanghai 100
Los Angeles 99
San Venanzo 96
Verona 93
Olalla 91
Palermo 90
Bern 88
Norwalk 87
Jakarta 85
Mahé 81
Genoa 80
Guangzhou 80
Jiaxing 80
Brussels 79
Redwood City 79
Catania 76
Redmond 75
Zhengzhou 73
Falls Church 69
Ningbo 66
Parma 66
Haikou 60
Helsinki 60
Taizhou 57
Hangzhou 54
Brescia 51
Bühl 45
Tokyo 45
Chicago 44
Kunming 44
New York 44
Hong Kong 43
London 43
Cagliari 42
Paris 41
Lima 39
Lanzhou 37
Lappeenranta 36
Shenzhen 36
Melbourne 35
Warsaw 35
Xi'an 35
Reggio Emilia 34
Mountain View 33
Perugia 33
Taiyuan 33
Amsterdam 32
Modena 32
Pescara 31
Wuhan 30
San Francisco 29
Monza 28
Rimini 25
Chengdu 24
Totale 38.626
Salva come PNG Salva come JPEG
Nome #
La fame d’amore: un bambino che sta bene non piange. 7.086
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 1.257
Lo studio Brisighella: 40 anni di ricerca nella prevenzione delle malattie cardiovascolari. 834
Combined action of SAMe, Folate, and Vitamin B12 in the treatment of mood disorders: a review. 596
I lactotripeptidi IPP e VPP riducono la pressione arteriosa sistolicanei soggetti europei? Una metaanlisi degli studi randomizzati controllati. 366
Capacità di efflusso del colesterolo e rigidità arteriosa nei soggetti sani: i dati del Brisighella Heart Study. 282
Miglioramento dell'hepatic steatosi index in pazienti dislipidemici ed in sovrappeso trattati con nutraceutici ipolipemizzanti. 265
Pharmanutrition and Functional food 225
A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels 193
Bioactive peptides in cereals and legumes: agronomical, biochemical and clinical aspects. 180
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study 162
Effect of apple polyphenols on vascular oxidative stress and endothelium function: A translational study 160
Cardiovascular risk factors and hearing impairment: a non-automatic correlation 153
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4. 152
A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence 151
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 150
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. 147
Nutraceutici ed alimenti funzionali in medicina preventiva. 142
Is the 2020 Sampson equation the best formula for LDL-C estimation? 142
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. 140
Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related with the lipid oxidative damage: the EUROLIVE Study. 140
Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the Brisighella Heart Study. 140
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials. 139
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. 138
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 138
Short-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical Trial 138
1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT 137
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10? 134
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load. 134
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 133
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. 133
Changes in peak systolic velocity induced by chronic therapy with phosphodiesterase type 5 inhibitor. 133
Arterial stiffness, sugar-sweetened beverages and fruits intake in a rural population sample: Data from the brisighella heart study 133
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. 132
null 131
Epidemiologia delle malattie cerebrovascolari. 130
Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects. 130
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study 128
Effects of a new low dose soy protein β-sitosterol association on plasma lipid levels and oxidation 127
Metabolic Syndrome prevalence in Italy. 126
Adverse reactions related to drugs for headache treatment: clinical impact. 126
Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study 126
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. 125
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. 125
Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. 125
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. 124
Relationship between lipid phenotypes, overweight, lipid lowering drug response and KIF6 and HMG-CoA genotypes in a subset of the brisighella heart study population 124
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. 123
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study. 123
Nutraceutical approach to Non-alcoholic fatty liver disease (NAFLD): the available clinical evidence. 122
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 121
Association between not HDL cholesterol levels and hypertension in the Brisighella Hart Study. 121
Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects. 121
Sources of variabilità of plasma HDL-cholesterol levels. 120
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. 120
Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. 120
An evidence-based review on urate-lowering treatments: Implications for optimal treatment of chronic hyperuricemia 120
Novel role of the nutraceutical bioactive compound Berberine in lectin-like OxLDL receptor 1 -mediated endothelial dysfunction in comparison to Lovastatin 120
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients. 119
2B02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE: DATA FROM THE BRISIGHELLA HEART STUDY 119
High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects 119
A Randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study 119
Rice bran and its main components: potential role in the management of cardiovascular disease risk. 118
null 118
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 118
Effects of lactotripeptides assumed as functional food on office and 24-hour blood pressure, stress-induced blood pressure increase, pulse wave velocity and cardiac output related parameters: a rondomized, double-blindd, clinical trial. 117
Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study. 117
Cocoa bioactive compounds: significance and potential for the maintenance of skin health. 117
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 117
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 116
REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies? 116
25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. 116
Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: the available clinical data 116
Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy. 115
Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study. 115
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. 114
Amount of physical activity in middle-age hypertensive patients. 114
Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. 114
The influence of statin medications on Prostate Specific Antigen levels. 113
Candesartan effect on inflammation in hypertension. 113
Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. 113
A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study. 113
Ruolo di lacidipina nel paziente iperteso 112
Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. 112
Physical activity, exercise and cardiovascular health 112
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. 112
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study 112
Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy. 112
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial. 111
The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography 110
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study. 110
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. 110
null 110
Natural sources of antidyslipidaemic agents: is there an evidence-based approach for their prescription? 109
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients 109
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 109
A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parametersand β-cell function 109
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). 108
L'attività fisica durante il tempo libero e la mortalità per malattie cardiovascolari: i dati del Brisighella Heart Study. 108
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial. 107
Totale 22.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.173 0 0 0 0 1.277 1.317 1.589 2.027 1.862 904 438 759
2020/20218.225 1.668 677 382 387 181 337 180 487 881 477 412 2.156
2021/20229.845 897 307 641 563 1.075 683 204 876 467 363 1.956 1.813
2022/202310.255 1.192 1.195 445 1.388 658 592 476 721 1.631 493 949 515
2023/20246.508 248 604 384 395 432 460 462 459 422 897 803 942
2024/202510.503 1.240 3.188 1.987 1.735 2.353 0 0 0 0 0 0 0
Totale 63.593